https://carrerasresearch.org/ca/publicacions/yes1-drives-lung-cancer-growth-and-progression-and-predicts-sensitivity-to-dasatinib/
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.